pathologic myopia
Showing 1 - 25 of 1,237
Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)
Completed
- Pathologic Myopia
- Intravitreal injection
-
Mykolaiv, Ukraine
- +2 more
Jan 23, 2023
Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)
Recruiting
- Pathologic Myopia
- Intravitreal injection
-
Lutsk, Ukraine
- +3 more
Mar 23, 2022
Learn More About How Drug Aflibercept Works in Canadian Reduced
Active, not recruiting
- Myopic Choroidal Neovascularization
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, CanadaMany Locations
Jul 25, 2022
Multiple Eye Fundus Diseases From Color Fundus Photograph
Completed
- Diabetic Retinopathy
- +12 more
- Software assisted imaging diagnosis
-
BeiJing, Beijing, China
- +4 more
Dec 28, 2021
Real Life Study in Myopic Neovascularization
Active, not recruiting
- Myopic Choroidal Neovascularisation
- AFLIBERCEPT
-
Poitiers, FranceChu de Poitiers
Sep 28, 2021
Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)
Recruiting
- Pathological Myopic Choroidal Neovascularization
-
BeiJing, ChinaPeking Union Medical College Hospital
Jun 4, 2021
Myopic Choroidal Neovascularisation Trial in Beijing (CM082)
Suspended
- Myopic Choroidal Neovascularisation
-
Beijing, ChinaPeking Union Medical College Hospital
Mar 7, 2021
Retinal Perforations, Myopia, Degenerative Trial in Hangzhou (corneal flap transplantation)
Active, not recruiting
- Retinal Perforations
- Myopia, Degenerative
- corneal flap transplantation
-
Hangzhou, Zhejiang, ChinaDepartment of Ophthalmology, Affiliated Hangzhou First People's
May 17, 2023
Optical Coherence Tomography Angiography Criteria Of The
Not yet recruiting
- Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
- Optical coherence tomography angiography
- (no location specified)
Sep 27, 2022
High Myopia, Axial Length, Eye Diseases Trial in Foshan (RLRL)
Not yet recruiting
- High Myopia
- +2 more
- RLRL
-
Foshan, Guangdong, ChinaThe Second People's Hospital of Foshan
Mar 2, 2023
High Myopia, Refractive Errors, Eye Diseases Trial in Shanghai (RLRL)
Not yet recruiting
- High Myopia
- +2 more
- RLRL
-
Shanghai, Shanghai, ChinaShanghai Eye Disease Prevention and Treatment Center
Oct 17, 2022
High Myopia: Extended and Longterm Observation of Pathologic
Completed
- Pathologic Myopia
- Observation & Diagnosis
-
Regensburg, Bavaria, Germany
- +25 more
Jul 18, 2019
PIC and Its Role in Progression of Pathological Myopia
Unknown status
- Punctate Inner Choroidopathy
-
Tokyo, JapanTokyo Medical and Dental University
Jun 15, 2021
Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM) Trial in Worldwide (Ranibizumab
Completed
- Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
- Ranibizumab 0.5mg
- +2 more
-
Beijing, Beijing, China
- +46 more
Mar 31, 2019
Glaucoma, Myopia Trial (0.5% pilocarpine eye drops)
Not yet recruiting
- Glaucoma
- Myopia
- 0.5% pilocarpine eye drops
- (no location specified)
Apr 24, 2022
Choroidal Neovascularization Secondary to Pathologic Myopia Trial in Italy (Ranibizumab)
Completed
- Choroidal Neovascularization Secondary to Pathologic Myopia
-
Ancona, AN, Italy
- +30 more
Oct 8, 2018
Myopia Trial in Australia, United States (Vivior)
Not yet recruiting
- Myopia
- Vivior
-
Berkeley, California
- +4 more
Nov 3, 2023
Refractive Error in Chinese University Students
Completed
- Refractive Error - Myopia Axial
- myopia or not myopia
-
Shanghai, Shanghai, ChinaShanghai Guanghua Integrated Traditional Chinese and Western Med
Dec 8, 2020
OCTA Insights in CNVM, Morphological Characteristics and
Not yet recruiting
- Choroidal Neovascularization
- (no location specified)
Sep 14, 2021
Vision Screening Study for College Students at Nankai University
Completed
- Myoma
- No intervention
-
Tianjin, Tianjin, ChinaTiajin Eye Hospital
Jun 28, 2023
Myopia, Progressive Trial in Shanghai (low concentration atropine (0.01%), low concentration atropine (0.02%), low concentration
Recruiting
- Myopia, Progressive
- low concentration atropine (0.01%)
- +3 more
-
Shanghai, Shanghai, ChinaXiangui He
Jul 10, 2023
Myopia Trial in Guangzhou (CARE1.02, Single-vision spectacle lens)
Not yet recruiting
- Myopia
- CARE1.02
- Single-vision spectacle lens
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Apr 17, 2023
Choroidal Neovascularization Trial in Guangzhou (0.5mg intravitreal ranibizumab)
Completed
- Choroidal Neovascularization
- 0.5mg intravitreal ranibizumab
-
Guangzhou, Guangdong, ChinaZhongShan Ophthalmic Center, Sun Yat-sen University
Mar 7, 2019
Shanghai Child and Adolescent Large-scale Eye Study -High Myopia
Enrolling by invitation
- High Myopia
- Pathologic Myopia
-
Shanghai, Shanghai, ChinaShanghai Eye Disease Prevention & Treatment Center
Sep 15, 2018